Havana, Cuba

Luis Enrique Molina

This inventor holds 2 USPTO granted patents. Top assignee: Centro De Inmunologia Molecular. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luis Enrique Molina. Retrieved from https://idiyas.com/inventor/luis-enrique-molina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Luis Enrique Molina Revolutionizing Cancer Treatment

Introduction: Luis Enrique Molina, a brilliant inventor based in Habana, Cuba, has made significant contributions to the field of medicine through his groundbreaking patents and innovative research. With a keen focus on developing vaccine compositions for eliciting immune responses against cancer cells, Molina's work is shaping the future of cancer treatment.

Latest Patents: Molina's latest patents showcase his cutting-edge approach to combating breast cancer. His inventions involve the novel uses of n-glycolylated gangliosides and N-acetylated gangliosides, along with their derivatives and oligosaccharides. These vaccine compositions are designed to trigger immune responses targeted at specific gangliosides present on breast tumor cells. By coupling these gangliosides to carriers and incorporating adjuvants, Molina's vaccines hold promise in the treatment of breast cancers.

Career Highlights: Luis Enrique Molina's career is distinguished by his commitment to scientific excellence and medical innovation. As a prominent figure at Centro de Inmunología Molecular, he has spearheaded numerous projects aimed at revolutionizing cancer therapies. Molina's dedication to research and development has led to the creation of impactful solutions with the potential to improve patient outcomes worldwide.

Collaborations: In his pursuit of scientific advancement, Molina has collaborated closely with esteemed colleagues such as Rolando Perez Rodriguez and Gilda Marquina Rodriguez. Together, they form a dynamic team dedicated to pushing the boundaries of medical innovation and redefining the landscape of cancer treatment.

Conclusion: Luis Enrique Molina's passion for innovation and his relentless pursuit of scientific breakthroughs make him a trailblazer in the field of medical research. His contributions to developing vaccine compositions for cancer immunotherapy demonstrate his unwavering commitment to improving the lives of patients affected by this devastating disease. As we look towards the future of healthcare, Molina's work stands as a testament to the transformative power of innovation in shaping a brighter tomorrow.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…